Publications by authors named "Gabriel Lamothe"

Claim this Profile
I
In Vitro Correction of Point Mutations in the Gene Using Prime Editing.
Camille Bouchard, Joël Rousseau, Gabriel Lamothe, Marie Dubost, Laura Bastrenta

Int J Mol Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Universal Prime Editing Therapeutic Strategy for RyR1-Related Myopathies: A Protective Mutation Rescues Leaky RyR1 Channel.
Kelly Godbout, Mathieu Dugas, Steven R Reiken, Sina Ramezani, Alexia Falle, Gabriel Lamothe

Int J Mol Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR-Cas9 delivery strategies with engineered extracellular vesicles.
Yaoyao Lu, Kelly Godbout, Gabriel Lamothe, Jacques P Tremblay

Mol Ther Nucleic Acids· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid and Technically Simple Detection of SARS-CoV-2 Variants Using CRISPR Cas12 and Cas13.
Gabriel Lamothe, Julie Carbonneau, Charles Joly Beauparlant, Thierry Vincent, Patrik Quessy

CRISPR J· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prime editing strategies to mediate exon skipping in gene.
Cedric Happi Mbakam, Jeanne Roustant, Joel Rousseau, Pouire Yameogo, Yaoyao Lu, Gabriel Lamothe

Front Med (Lausanne)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR-Cas9 Gene Therapy for Duchenne Muscular Dystrophy.
Cedric Happi Mbakam, Gabriel Lamothe, Guillaume Tremblay, Jacques P Tremblay

Neurotherapeutics· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular Dystrophy.
Cedric Happi Mbakam, Gabriel Lamothe, Jacques P Tremblay

Front Med (Lausanne)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Base editing strategy for insertion of the A673T mutation in the APP gene to prevent the development of AD .
Antoine Guyon, Joël Rousseau, Francis-Gabriel Bégin, Tom Bertin, Gabriel Lamothe

Mol Ther Nucleic Acids· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The protective mutation A673T in amyloid precursor protein gene decreases Aβ peptides production for 14 forms of Familial Alzheimer's Disease in SH-SY5Y cells.
Antoine Guyon, Joël Rousseau, Gabriel Lamothe, Jacques P Tremblay

PLoS One· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis